Cargando…

Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation

OBJECTIVES: To compare the diagnostic performance of international hepatocellular carcinoma (HCC) guidelines with gadoxetic acid-enhanced MRI (EOB-MRI) and contrast-enhanced Computed tomography (CECT) and their impact on liver transplant (LT) allocation in cirrhotic patients with explant histopathol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Odedra, Devang, Jandaghi, Ali Babaei, Bhayana, Rajesh, Elbanna, Khaled Y., Espin-Garcia, Osvaldo, Fischer, Sandra E., Ghanekar, Anand, Sapisochin, Gonzalo, Jhaveri, Kartik S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531508/ https://www.ncbi.nlm.nih.gov/pubmed/36195953 http://dx.doi.org/10.1186/s40644-022-00497-9

Ejemplares similares

Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation
por: Jhaveri, Kartik S., et al.
Publicado: (2023)

Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?
por: Jhaveri, Kartik S., et al.
Publicado: (2021)

Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
por: Islam, S, et al.
Publicado: (2015)

Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
por: Huh, Jimi, et al.
Publicado: (2019)

Quantification of liver function using gadoxetic acid-enhanced MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2020)

Current Approaches in the Allocation of Liver Transplantation
por: Ionescu, Vlad Alexandru, et al.
Publicado: (2022)

The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases
por: Gorgen, Andre, et al.
Publicado: (2018)

Ex vivo hepatic venography for hepatocellular carcinoma in livers explanted for liver transplantation
por: Miyazaki, Kensuke, et al.
Publicado: (2011)

Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver
por: Huh, Jimi, et al.
Publicado: (2015)

Recent advances in liver transplantation for cancer: The future of transplant oncology
por: Abreu, Phillipe, et al.
Publicado: (2019)

Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?
por: Andres, Axel, et al.
Publicado: (2021)

Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?
por: Goldaracena, Nicolas, et al.
Publicado: (2015)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
por: Song, Kyoung Doo, et al.
Publicado: (2015)

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)

Features of Nodules in Explants of Children Undergoing Liver Transplantation for Biliary Atresia
por: Calinescu, Ana M., et al.
Publicado: (2022)

Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity
por: Hojreh, Azadeh, et al.
Publicado: (2023)

Organ Allocation for Liver Transplantation According to the Public Opinion
por: Danesh, Ahmad, et al.
Publicado: (2012)

Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Renal Dysfunction After Liver Transplantation: Effect of Donor Type
por: Kollmann, Dagmar, et al.
Publicado: (2020)

Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure
por: Zhu, Wang-Shu, et al.
Publicado: (2020)

Indeterminate liver lesions on gadoxetic acid-enhanced magnetic resonance imaging of the liver: Case-based radiologic-pathologic review
por: Noreikaite, Jurate, et al.
Publicado: (2021)

Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation
por: Kollmann, Dagmar, et al.
Publicado: (2018)

Trends in liver transplantation for autoimmune liver diseases: a Canadian study
por: Murillo Perez, Carla F., et al.
Publicado: (2022)

Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?
por: Barbas, Andrew S., et al.
Publicado: (2018)

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021)

Impact of Different Creatinine Measurement Methods on Liver Transplant Allocation
por: Kaiser, Thorsten, et al.
Publicado: (2014)

Fair is fair: We must re-allocate livers for transplant
por: Parent, Brendan, et al.
Publicado: (2017)

Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
por: Amorim, Viviane Brandão, et al.
Publicado: (2020)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
por: Wang, Qiang, et al.
Publicado: (2021)

Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid–enhanced liver MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2022)

Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center
por: Ha, Hea-Seon, et al.
Publicado: (2019)

Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection
por: Granata, Vincenza, et al.
Publicado: (2019)

Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma
por: Jin, Young-Joo, et al.
Publicado: (2017)

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases
por: Hernandez-Alejandro, Roberto, et al.
Publicado: (2022)

Segmental Distribution of Hepatocellular Carcinoma Correlates with Microvascular Invasion in Liver Explants Undergoing Transplantation
por: Al-Azzawi, Yasir, et al.
Publicado: (2019)

Attitudes of Canadian Colorectal Cancer Care Providers towards Liver Transplantation for Colorectal Liver Metastases: A National Survey
por: Guidolin, Keegan, et al.
Publicado: (2022)

Does Microvascular Invasion Affect Outcomes After Liver Transplantation for HCC? A Histopathological Analysis of 155 Consecutive Explants
por: Shah, Shimul A., et al.
Publicado: (2007)

Corrigendum to: Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center
por: Ha, Hea-Seon, et al.
Publicado: (2021)

Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
por: Mazzaferro, Vincenzo
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l1nhv84rc79o9m1bvjro6k556r